MLV & Co. Sees Good Things Ahead For Cytokinetics By: Benzinga via Benzinga September 02, 2014 at 08:47 AM EDT In a report published Tuesday, MLV & Co. analyst George B. Zavoico reiterated a Hold rating and $5.00 price target on Cytokinetics ... Read More >> Related Stocks: Cytokinetics